HU9301327D0 - Method and device for energy-saving optimization of microclimate of animal keepling buildings - Google Patents

Method and device for energy-saving optimization of microclimate of animal keepling buildings

Info

Publication number
HU9301327D0
HU9301327D0 HU931327A HU132793A HU9301327D0 HU 9301327 D0 HU9301327 D0 HU 9301327D0 HU 931327 A HU931327 A HU 931327A HU 132793 A HU132793 A HU 132793A HU 9301327 D0 HU9301327 D0 HU 9301327D0
Authority
HU
Hungary
Prior art keywords
keepling
microclimate
buildings
animal
energy
Prior art date
Application number
HU931327A
Other languages
English (en)
Other versions
HUT70500A (en
Inventor
Ming Fai Chan
David Frederick Woodward
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of HU9301327D0 publication Critical patent/HU9301327D0/hu
Publication of HUT70500A publication Critical patent/HUT70500A/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Feedback Control In General (AREA)
  • Geophysics And Detection Of Objects (AREA)
  • Medicinal Preparation (AREA)
HU9301327A 1990-11-09 1991-10-30 Et process to prepare 2-decarboxyl-2-aminoalkyl-prostaglandine derivs and pharmaceutical compns. contg them as active agent for use as ocular hypotensives HUT70500A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/611,029 US5270049A (en) 1990-11-09 1990-11-09 2-decarboxyl-2-aminoalkyl-prostaglandins as ocular hypotensives

Publications (2)

Publication Number Publication Date
HU9301327D0 true HU9301327D0 (en) 1993-09-28
HUT70500A HUT70500A (en) 1995-10-30

Family

ID=24447325

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9301327A HUT70500A (en) 1990-11-09 1991-10-30 Et process to prepare 2-decarboxyl-2-aminoalkyl-prostaglandine derivs and pharmaceutical compns. contg them as active agent for use as ocular hypotensives

Country Status (15)

Country Link
US (1) US5270049A (hu)
EP (1) EP0556296B1 (hu)
JP (1) JP3488456B2 (hu)
AT (1) ATE158506T1 (hu)
AU (1) AU656752B2 (hu)
BR (1) BR9107071A (hu)
CA (1) CA2095430A1 (hu)
DE (1) DE69127755T2 (hu)
ES (1) ES2107522T3 (hu)
HU (1) HUT70500A (hu)
IE (1) IE913906A1 (hu)
IL (1) IL99975A (hu)
NZ (1) NZ240502A (hu)
WO (1) WO1992008465A2 (hu)
ZA (1) ZA918869B (hu)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5288754A (en) * 1992-02-04 1994-02-22 Allergan, Inc. Polar C-1 esters of prostaglandins
US5834498A (en) * 1992-09-21 1998-11-10 Allergan Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
US5688819A (en) * 1992-09-21 1997-11-18 Allergan Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5352708A (en) * 1992-09-21 1994-10-04 Allergan, Inc. Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5972991A (en) 1992-09-21 1999-10-26 Allergan Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
US5328933A (en) * 1992-10-28 1994-07-12 Allergan, Inc. Cyclopentane heptenylnitro and heptanylnitro-2-aliphatic or aryl aliphatic derivatives and homologues
US6124353A (en) * 1992-11-12 2000-09-26 Allergan Sales, Inc. Method of treating ocular hypertension with 8-epi prostaglandins
US5545665A (en) * 1993-12-28 1996-08-13 Allergan Cyclopentane(ene) heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents
US5698733A (en) * 1994-09-30 1997-12-16 Alcon Laboratories, Inc. Use of 9-deoxy prostaglandin derivatives to treat glaucoma
WO1998021180A1 (en) 1995-06-07 1998-05-22 Alcon Laboratories, Inc. Conformationally rigid aryl- or heteroaryl prostaglandins for use in glaucoma therapy
US6646001B2 (en) 1997-12-19 2003-11-11 Alcon Manufacturing, Ltd. Use of non-steroidal anti-inflammatory agents in combination with prostaglandin FP receptor agonists to treat glaucoma and ocular hypertension
US6066671A (en) 1997-12-19 2000-05-23 Alcon Laboratories, Inc. Treatment of GLC1A glaucoma with 3-benzoyl-phenylacetic acids, esters, or amides
US6096783A (en) * 1998-12-15 2000-08-01 Alcon Laboratories, Inc. Cyclobutane prostaglandin analogues as ocular hypotensive agents
US6211226B1 (en) 1998-12-17 2001-04-03 Alcon Laboratories, Inc. 11-Aza prostaglandins for the treatment of glaucoma and ocular hypertension
US6160013A (en) * 1998-12-17 2000-12-12 Alcon Laboratories, Inc. 14-aza prostaglandins for the treatment of glaucoma and ocular hypertension
US20090148527A1 (en) * 2007-12-07 2009-06-11 Robinson Michael R Intraocular formulation
US9241918B2 (en) 2005-03-16 2016-01-26 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US7851504B2 (en) 2005-03-16 2010-12-14 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US9522153B2 (en) 2009-12-22 2016-12-20 Allergan, Inc. Compositions and methods for lowering intraocular pressure

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4122282A (en) * 1975-12-29 1978-10-24 The Upjohn Company 2-Decarboxy-2-carboxyamino-methyl-PGFα compounds
US4599353A (en) * 1982-05-03 1986-07-08 The Trustees Of Columbia University In The City Of New York Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma
US4883819A (en) * 1986-07-31 1989-11-28 The Trustees Of Columbia University In The City Of New York Use of A, B and C prostaglandins and derivatives thereof to treat ocular hypertension and glaucoma
DE3785602T2 (de) * 1986-03-13 1993-09-02 Univ Columbia Verwendung von a-, b- und c-prostaglandinen und deren derivaten zur behandlung von augen-hypertension und glaukom.
US4824857A (en) * 1986-05-16 1989-04-25 Yasumasa Goh Use of prostaglandin D2 -active substances
US4952581A (en) * 1987-04-03 1990-08-28 The Trustees Of Columbia University In The City Of New York Use of a prostaglandin in combination with an adrenergic blocking agent for reduction of intraocular pressure
ES2052735T3 (es) * 1987-09-18 1994-07-16 R Tech Ueno Ltd Un metodo para producir un agente hipotensor ocular.
US4927846A (en) * 1988-11-23 1990-05-22 Allergan, Inc. Intraocular pressure reducing 1,11-lactone prostaglandins
US4994274A (en) * 1989-07-27 1991-02-19 Allergan, Inc. Intraocular pressure reducing 11,15-diacyl prostaglandins and method of using
US5011856A (en) * 1990-03-12 1991-04-30 Allergan, Inc. Use of prostaglandin F3 α as an ocular hypotensive agent
US5238961A (en) * 1990-06-14 1993-08-24 Allergan, Inc. Pgf 1-alcohols and their use as ocular hypotensives

Also Published As

Publication number Publication date
JPH06501482A (ja) 1994-02-17
NZ240502A (en) 1995-07-26
EP0556296A1 (en) 1993-08-25
IL99975A0 (en) 1992-08-18
AU656752B2 (en) 1995-02-16
ES2107522T3 (es) 1997-12-01
WO1992008465A3 (en) 1992-10-15
US5270049A (en) 1993-12-14
EP0556296B1 (en) 1997-09-24
IE913906A1 (en) 1992-05-20
DE69127755T2 (de) 1998-04-30
HUT70500A (en) 1995-10-30
AU9041491A (en) 1992-06-11
ATE158506T1 (de) 1997-10-15
IL99975A (en) 1996-05-14
BR9107071A (pt) 1993-09-21
DE69127755D1 (de) 1997-10-30
WO1992008465A2 (en) 1992-05-29
CA2095430A1 (en) 1992-05-10
ZA918869B (en) 1992-07-29
JP3488456B2 (ja) 2004-01-19

Similar Documents

Publication Publication Date Title
HU9301327D0 (en) Method and device for energy-saving optimization of microclimate of animal keepling buildings
ES2138691T3 (es) Procedimiento para la obtencion de derivados de n-acil-5-fluorocitidina.
ES2145915T3 (es) Derivados estereoquimicos de la wortmannina.
DK45889D0 (da) Fremgangsmaade til hoereapparattilpasning
FI931916A0 (fi) Transdermala befruktningshindrande formuleringar, metoder och anordningar
ITMI912529A0 (it) Procedimento per la produzione di carbonati alchilici
IT1271405B (it) Cilindro per la guida di nastri
MA23044A1 (fr) Derives insecticides de 2,4-dianinopyrimidines-5-substitues.
MX9204635A (es) Procedimiento para la preparacion de derivados de beta-fenilisoserina.
FI951377A (fi) N-asetyylineuramiinihappojohdannaisten synteesi
ITMI931935A0 (it) Procedimento per combattere insetti
BR9100315A (pt) Composto,composicao lubrificante,metodo de estabilizacao de lubrificantes
ES2160893T3 (es) Procedimiento y compuestos intermedios para la preparacion de compuestos de fluoroolefinas plaguicidas.
KR950700297A (ko) 5-HT3-수용체 길항제로서의 2,6-메타노-2H-퀴놀리진 유도체(2,6-Methano-2H-quinolizin derivative as 5-HT3-receptor antagonist)
FR2681068B1 (fr) Procede de preparation de l'isomere dextrogyre d'un derive de l'isoindolinone.
MA22589A1 (fr) Procede de preparation de l'isomere dextrogyre d'un derive de l'isoindolinone
NO921317D0 (no) Antimetastatisk virkende midler
KR960000703U (ko) 레이저 마커의 스플리터 이송장치
ES2094975T3 (es) Procedimiento para la preparacion de 1,3-dialquil-5-hidroxioxindoles y sus derivados de eter.
KR970019153U (ko) 오버 헤드 프로젝트의 헤드 높낮이 자동 조절장치
FR2661911B1 (fr) Procede de preparation de derives de la thieno-triazolo-diazepine.
ITRE910021U1 (it) Box per la stabulazione dei suini.
NO892740D0 (no) Sidereguleringsanordning for jordbruksredskaper.
FI902356A0 (fi) Tieno-triatsolo-diatsepiinijohdosten valmistusmenetelmä
ITMI920629A0 (it) Procedimento per la preparazione di un derivato chinolonico solforato

Legal Events

Date Code Title Description
DFD9 Temporary protection cancelled due to non-payment of fee
DNF4 Restoration of lapsed final protection
DFD9 Temporary protection cancelled due to non-payment of fee